| __timestamp | Eli Lilly and Company | Protagonist Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4733600000 | 7459000 |
| Thursday, January 1, 2015 | 4796400000 | 11831000 |
| Friday, January 1, 2016 | 5243900000 | 25705000 |
| Sunday, January 1, 2017 | 5281800000 | 46181000 |
| Monday, January 1, 2018 | 5051200000 | 59497000 |
| Tuesday, January 1, 2019 | 5595000000 | 65003000 |
| Wednesday, January 1, 2020 | 6085700000 | 74506000 |
| Friday, January 1, 2021 | 7025900000 | 126006000 |
| Saturday, January 1, 2022 | 7190800000 | 126215000 |
| Sunday, January 1, 2023 | 9313400000 | 120161000 |
| Monday, January 1, 2024 | 14271000000 |
Unleashing the power of data
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Eli Lilly and Company, a giant in the industry, has consistently increased its R&D expenses over the past decade. From 2014 to 2023, Eli Lilly's R&D spending surged by nearly 97%, reflecting its strategic focus on developing new therapies. In contrast, Protagonist Therapeutics, Inc., a smaller player, has shown a remarkable growth trajectory, with its R&D expenses increasing by over 1,500% during the same period. This stark difference highlights the varied approaches companies take in their quest for breakthroughs. While Eli Lilly leverages its vast resources to maintain a steady growth in R&D, Protagonist Therapeutics is rapidly scaling its efforts, signaling its ambition to make a mark in the industry. These trends underscore the dynamic nature of pharmaceutical innovation.
Eli Lilly and Company or Vertex Pharmaceuticals Incorporated: Who Invests More in Innovation?
Who Prioritizes Innovation? R&D Spending Compared for Eli Lilly and Company and Madrigal Pharmaceuticals, Inc.
Eli Lilly and Company vs Lantheus Holdings, Inc.: Strategic Focus on R&D Spending
Comparing Innovation Spending: Eli Lilly and Company and Ionis Pharmaceuticals, Inc.
Comparing Innovation Spending: Eli Lilly and Company and ADMA Biologics, Inc.
Eli Lilly and Company or Alkermes plc: Who Invests More in Innovation?
Research and Development Investment: Eli Lilly and Company vs Perrigo Company plc
R&D Spending Showdown: Eli Lilly and Company vs ACADIA Pharmaceuticals Inc.
Eli Lilly and Company or Ligand Pharmaceuticals Incorporated: Who Invests More in Innovation?
Comparing Innovation Spending: CRISPR Therapeutics AG and Protagonist Therapeutics, Inc.
Research and Development Expenses Breakdown: Veracyte, Inc. vs Protagonist Therapeutics, Inc.
Research and Development Investment: Protagonist Therapeutics, Inc. vs Evotec SE